Related Experiment Video
Updated: Jul 14, 2026
09:32
A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Published on: September 23, 2014
A perspective on DNA microarrays in pathology research and practice
1Department of Pathology, Stanford University School of Medicine, CCSR-3245A, 269 Campus Dr., Stanford, CA 94305-5176, USA. pollack1@stanford.edu
The American Journal of Pathology
|June 30, 2007
Summary
DNA microarrays offer powerful tools for cancer research and disease classification in pathology. Challenges remain in translating this technology
Area of Science:
- Molecular pathology
- Genomics
- Biotechnology
Background:
- DNA microarray technology emerged in the mid-1990s, revolutionizing molecular diagnostics.
- Significant growth in DNA microarray applications over the last decade.
- Established as essential tools for pathology researchers in disease description and classification.
Discussion:
- This review highlights key contributions of DNA microarrays in experimental pathology, particularly in cancer research.
- Explores the potential of DNA microarrays to advance pathology practice.
- Addresses the challenges in translating DNA microarray utility into clinical settings.
Key Insights:
- DNA microarrays have significantly enhanced the understanding of human diseases, especially cancers.
- The technology facilitates detailed molecular profiling for disease characterization.
- Successful application in experimental pathology, providing a foundation for clinical advancements.
Outlook:
- Future directions involve overcoming current limitations for broader clinical adoption.
- Continued innovation in microarray technology promises further integration into diagnostic pathology.
- Potential for personalized medicine through advanced genomic analysis.
